Insulet Corporation (PODD)
NASDAQ
Closed
Oct 8, 2026
Day's Range
132.8652 wk Range
126.40Overview - PODD - Insulet Corporation
Key Statistics
Valuation
Enterprise Value
9.54B
P/E (Trailing)
‪24.66‬
P/E (Forward)
‪17.06‬
PEG Ratio
‪0.07‬
Price / Sales (TTM)
‪2.99‬
Price / Book
‪6.42‬
EV / EBITDA
‪15.52‬
Profitability
Gross Margin
‪70.17%‬
Profit Margin
‪12.29%‬
Operating Margin
‪16.17%‬
Return on Assets
‪9.71%‬
Return on Equity
‪26.01%‬
Ownership
Shares Outstanding
69.35M
Float
69.06M
Short % of Shares Outstanding
‪8.27%‬
Held by Insiders
‪0.32%‬
Held by Institutions
‪107.00%‬
Price stats
Beta
‪1.07‬
50-Day Avg
‪145.77‬
200-Day Avg
‪194.17‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
25 analysts
Average price target
‪$ 171.91‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - PODD - Insulet Corporation
Peers - PODD - Insulet Corporation
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
- PODDNASDAQInsulet Corporation9.13BMarket Cap-136.69%52-week change24.66P/E (Trailing)‪12.29%‬Profit Margin
- DXCMNASDAQDexCom Inc.32.21BMarket Cap+22.26%52-week change33.74P/E (Trailing)‪20.11%‬Profit Margin
- GEHCNASDAQGE HealthCare Technologies Inc.29.24BMarket Cap-18.85%52-week change14.81P/E (Trailing)‪9.33%‬Profit Margin
- BRKRNASDAQBruker Corp.9.63BMarket Cap+42.35%52-week change74.88P/E (Trailing)‪-2.03%‬Profit Margin
- TLTLTNASDAQiShares 20+ Year Treasury Bond ETF9.46BMarket Cap-14.44%52-week change—P/E (Trailing)—Profit Margin
- LIVNNASDAQLivaNova PLC4.13BMarket Cap+29.89%52-week change22.01P/E (Trailing)‪12.81%‬Profit Margin
- IRTCNASDAQiRhythm Holdings, Inc.3.63BMarket Cap-59.23%52-week change-79.45P/E (Trailing)‪-1.69%‬Profit Margin
Profile Summary - PODD - Insulet Corporation
About
Insulet Corporation is a medical device company focused on insulin delivery and diabetes management. Its flagship Omnipod platform includes wearable, tubeless insulin management systems designed to deliver continuous insulin without traditional pump tubing or multiple daily injections. The product line includes…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
